Suzetrigine versus oxycodone for pain after knee replacement surgery
Compares suzetrigine with oxycodone for pain after knee replacement in people with knee osteoarthritis.
Key facts
- Who runs it
- University of Louisville
- Where
- Louisville, United StatesSee the site
- Trial code
- Registry title
- Comparison of Suzetrigine and Oxycodone for Postoperative Pain After Primary Total Knee Arthroplasty
- Status
- Enrolling by invitation
- Phase
- Phase 4
- People taking part
- 140 people, planned
- Started
- 9 Feb 2026
- Expected to end
- 30 Apr 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- oral suzetrigine
- oral Oxycodone
- Record updated
- 4 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with knee osteoarthritis who are scheduled for a first total knee replacement on one knee. It compares suzetrigine with Oxycodone for pain after surgery.
- Age
- 21 to 89 years at the time of surgery
- Sex
- All sexes
- Disease stage
- Osteoarthritis of the knee, with a planned first (primary) total knee replacement on one side only
- Earlier treatment
- People cannot join if they took opioids in the 90 days before enrolment.
Main reasons for not taking part
- Main diagnosis is not osteoarthritis
- Unable to read and speak English
- Allergy to suzetrigine or a reason it cannot be used
- Pregnant or breastfeeding
- Opioid use in the 90 days before enrolment
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patient age is 21-89 at time of surgery
- Patient is scheduled to undergo a unilateral primary TKA, secondary to osteoarthritis
- Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization document
- Patient is able to read and speak English
Who cannot take part
- Patient has taken opioids within the 90 days prior to enrollment
- Contraindication or Hypersensitivity to suzetrigine
- Patient is under the age of 21
- Patient's primary diagnosis is not osteoarthritis
- Patient is unable to read and speak English
- Pregnant or nursing females
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 89 years old?
Where in United States
- UofL HealthLouisville, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The purpose this study is determine whether postoperative oral dosage of suzetrigine is effective at controlling postoperative pain and reducing analgesic requirements following primary total knee arthroplasty (TKA) versus a control group of TKA patients receiving postoperative Oxycodone.
The 2 groups in the trial
- Group A: suzetrigine groupTreatment being tested
Participant will receive a two-week supply of oral suzetrigine upon discharge. Participant will also receive a 10-pill supply of Oxycodone as a rescue medication.
Treatment: oral suzetrigine
- Group B: Oxycodone groupExisting treatment, for comparison
Participant will receive a two-week supply of oral Oxycodone upon discharge
Treatment: oral Oxycodone
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Comparison of Suzetrigine and Oxycodone for Postoperative Pain and Analgesic Requirements After Primary Total Knee Arthroplasty: a Prospective, Randomized Study
- Plain-language title
- Suzetrigine versus oxycodone for pain after knee replacement surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07219888, who can take part
- Record updated
- 4 May 2026